Global Vaccine Packaging Market Report 2022-2025: High-income countries will lead demand for vaccines and related packaging


DUBLIN, April 12, 2022 /PRNewswire/ — Added Global Vaccine Packaging to 2025 report Offer.

Global demand for vaccine packaging is expected to grow at 6.9% annually $3.6 billion in 2025.

By 2022 and 2023, the increasing availability and use of vaccines to fight COVID-19 will result in a significant increase in demand for vaccine packaging. However, the market is expected to settle down by 2025 as the pandemic is brought under control, mass immunization efforts take hold and average vaccine prices fall as production normalizes and a higher proportion of doses are sold to low-income countries will.

However, as the COVID-19 pandemic continues to unfold, the outlook for vaccine packaging could change. The development of SARS-CoV-2 variants, new data on the effectiveness of vaccines against new variants and the continued campaign to vaccinate and strengthen the world’s population could change forecasts for a variety of packaging products.

Glass vials remain popular but are facing increasing competition from prefillable syringes

Glass vials will be among the most commonly used types of vaccine packaging due to their low cost, strong barrier properties and breadth of applications served. Short-term demand is being supported by the widespread adoption of COVD-19 vaccines packaged exclusively in glass vials in 2020 and 2021 as mass immunization campaigns around the world made multi-dose packaging both efficient and effective.

However, prefillable syringes – which pose a much lower risk of cross-contamination and are easier to use as they require no pre-injection preparation – continue to offer strong competition to multi-dose glass vial packaging. As the global vaccination rate for COVID-19 increases, more doses are likely to be packaged in prefilled syringes, reducing waste when not many people need doses at the same time.

High-income countries will lead in vaccine production and associated packaging demand

The activities of progressive pharmaceutical companies such as GlaxoSmithKline, Merck, Pfizer and Sanofi reflect high-income countries in North America, Western Europeand Asia/Pacific as a group will account for a much larger share of the value of global vaccine production and associated packaging demand than companies with developing vaccine industries.

Based on the operation of broad pharmaceutical industries, China and India will include the largest vaccine manufacturers and packaging consumers among countries with developing vaccine and pharmaceutical markets.

Factors driving this gain include:

  • Continued worldwide use of established vaccines to prevent diseases such as diphtheria-whooping-tetanus, human papillomavirus (HPV), measles-mumps-rubella, meningitis, pneumonia, rotavirus and seasonal influenza
  • Expand and improve preventive medical activities, including government-sponsored mass vaccination of vulnerable age groups
  • Expanding public educational resources to promote the benefits of vaccines, encourage their wider use, and prevent the spread of disinformation about them
  • The increasing use of higher quality vaccine packaging systems with improved barrier, safety and usability features

Main topics covered:

1. Summary

2. About this report

  • Report Details
  • Scope of study and product description
  • Effects of the COVID-19 pandemic

3. Overview

  • Historical Market Trends
  • Overview of the global vaccine market
  • Global trends in vaccine production
  • Vaccine Packaging Demand by Region
  • Leading country markets
  • Market share and leading manufacturers

4. Packaging Products

  • demand for type
  • glass vial
  • Prefillable Syringes
  • vial caps
  • Secondary vaccine packaging
  • Other vaccine packaging products

5. COVID-19 packaging issues

  • Covid-19 vaccinations
  • Pfizer/BioNTech vaccine
  • Moderna/National Institute of Allergy and Infectious Diseases Vaccine
  • AstraZeneca/University of Oxford vaccination
  • Janssen/Johnson & Johnson vaccine
  • Novavax
  • Sinopharm
  • CanSino Biologics
  • Sinovac Biotech
  • covaxin
  • Gameleya Research Institute
  • Global vaccination rates
  • COVID-19 vaccine production
  • Demand for COVID-19 vaccine packaging
  • Supply chain issues/bottlenecks in glass vials
  • New product development

For more information about this report, visit

Media contact:

research and markets
Laura WoodSenior managers
[email protected]

For EST office hours, call +1-917-300-0470
For US/CAN, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

decision View original content:–related-packaging – Demand-301523816.html

SOURCE Research and Markets


Comments are closed.